AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ESCITALOPRAM OXALATE
38 registrations across 8 African markets— 28 active
Markets with ESCITALOPRAM OXALATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ESLOZ-10 TABLETS (Each tablet contains Escitalopram Oxalate 10 mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| ESLOZ-20 TABLETS (Each tablet contains Escitalopram Oxalate 20 mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| ESLOZ-10 TABLETS (Each tablet contains Escitalopram Oxalate 10 mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| ESLOZ-20 TABLETS (Each tablet contains Escitalopram Oxalate 20 mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| FELIZ S 10 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | TORRENT EXPORTS LTD | active | Dec 2030 |
| CP-ESCITALOPRAM 20 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | COSPHARM PHARMACEUTICALS | active | Sept 2030 |
| CP-ESCITALOPRAM 10 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | COSPHARM PHARMACEUTICALS | active | Sept 2030 |
| STALOMAC 20 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | MACLEODS PHARMACEUTICALS LIMITED | active | Dec 2027 |
| STALOMAC 10 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | MACLEODS PHARMACEUTICALS LIMITED | active | Dec 2027 |
| ECINIL 10MG TABLETS Film-Coated Tablet | 🇰🇪Kenya | Sai Pharmaceuticals Limited | active | Aug 2027 |
| ESCIGRESS 10 TABLETS | 🇬🇭Ghana | — | active | Apr 2027 |
| ESCIGRESS 10 TABLETS | 🇬🇭Ghana | — | active | Apr 2027 |
| ESCIGRESS 5 Tablet | 🇰🇪Kenya | LA RENON HEALTHCARE PRIVATE LIMITED | active | Sept 2026 |
| ESCITALOPRAM BE-TABS 5 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| ESCITALOPRAM BE-TABS 10 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| ESCITALOPRAM BE-TABS 20 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| ESCIGRESS_5 5MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2022 |
| EC-PRAM_10 10MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2020 |
| ESTA 20MG COMPRIME BOITE DE 14 | 🇨🇮Côte d'Ivoire | BRAWN LABORATORIES LIMITED | expired | Aug 2019 |
| CILENTRA_20 20MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2014 |
| ISOFIL 20MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2014 |
| ISOLIFT 10MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2014 |
| CILENTRA_10 10MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2014 |
| LEXAMIL 5 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| LEXAMIL 20 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| LEXAMIL 10 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| ASCIPRAM-10 CP PELL BTE(3 X 10) MICRO LABS Comprimé pelliculé, boîte de 3 | 🇲🇬Madagascar | MICRO LABS LTD (No. 27) | active | — |
| ASCIPRAM-20 CP PELL BTE(3 X 10) MICRO LABS Comprimé pelliculé, boîte de 3 | 🇲🇬Madagascar | MICRO LABS LTD (No. 31) | active | — |
| ESCITALOPRAM
OXALATE ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | LA RENON HEALTHCARE PRIVATE LIMITED | active | — |
| ASCIPRAM-10 CP PELL BTE(3 X 10) MICRO LABS Comprimé pelliculé, boîte de 3 | 🇲🇬Madagascar | MICRO LABS LTD (No. 27) | active | — |
| ESCITALOPRAM
OXALATE ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | THE SEARLE COMPANY LIMITED | active | — |
| ESCITALOPRAM
OXALATE ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | LA RENON HEALTHCARE PRIVATE LIMITED | active | — |
| ESCITALOPRAM
OXALATE ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | LA RENON HEALTHCARE PRIVATE LIMITED | active | — |
| ASCIPRAM-20 CP PELL BTE(3 X 10) MICRO LABS Comprimé pelliculé, boîte de 3 | 🇲🇬Madagascar | MICRO LABS LTD (No. 31) | active | — |
| ESCITALOPRAM
OXALATE ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | THE SEARLE COMPANY LIMITED | active | — |
| ESCITALOPRAM
OXALATE ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | LA RENON HEALTHCARE PRIVATE LIMITED | active | — |
| ESCITALOPRAM
OXALATE ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | THE SEARLE COMPANY LIMITED | active | — |
| ESCITALOPRAM
OXALATE ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | THE SEARLE COMPANY LIMITED | active | — |
ESCITALOPRAM OXALATE in Africa — Regulatory Overview
ESCITALOPRAM OXALATE is registered across 8 African markets with 38 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Malawi, Ghana, South Africa and 4 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 38 registrations, 28 (74%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.